CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases
- 18 May 2021
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 114, 66-73
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- How I treat T-cell acute lymphoblastic leukemia in adultsBlood, 2015
- EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsLeukemia, 2012
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesLeukemia, 2012
- Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007Blood, 2012
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Precursor T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma and Acute Biphenotypic LeukemiasAmerican Journal of Clinical Pathology, 2007
- The Immunophenotype of 325 Adult Acute LeukemiasAmerican Journal of Clinical Pathology, 2002
- Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometryBritish Journal of Haematology, 1996
- Lineage determination of CD7+ CD5− CD2− and CD7+ CD5+ CD2− lymphoblasts: Studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3ϵ, and CD3δAmerican Journal of Hematology, 1994
- Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues.Journal of Experimental Medicine, 1988